In IBD, the involvement of the CX3CL1–CX3CR1 axis regulates macrophage and intestinal immune function, and deletion of CX3CL1 and CX3CR1 results in the translocation of the gut microbiome and enhances IBD severity [6]. This evidence concerns the gene CX3CL1 and inflammatory bowel disease.